香港股市 已收市

大學光 (3218.TWO)

Taipei Exchange - Taipei Exchange 延遲價格。貨幣為 TWD。
加入追蹤清單
253.50-1.50 (-0.59%)
收市:01:30PM CST

大學光

No.3-1 Yuanqu Street
4th Floor Nangang District
Taipei 115
Taiwan
886 2 2655 8000
https://www.uvb.com.tw/

版塊Healthcare
行業Medical Devices
全職員工

高階主管

名稱頭銜支付行使價出生年份
Mr. Pi-Jung LinFounder, President, CTO & Representative Director2.92M
Cindy SunDirector of Finance & Accounting
Mr. Yu-chi ChanDirector of Human Resources & Administration Division
Mr. Chien-Hsiang YuDirector of Marketing Division
Ms. Shu-Hsin LinChief Auditor of Audit Office
截止 2021年12月31日為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 TWD。

描述

Universal Vision Biotechnology Co., Ltd. operates a chain of eye care clinics in Taiwan and China. Its clinic provides laser vision correction surgery for myopia, hyperopia, astigmatism, and presbyopia; intraocular lens surgery for presbyopia and cataract; phacoemulsification and femtosecond laser for cataract surgery; and myopia control services, as well as services for dry eyes, retinal detachment, macular degeneration, strabismus, amblyopia, and other eye diseases. The company also offers vision products and services, including a range of eyeglass frames, multifocal and progressive lenses for myopia and presbyopia, sunglasses, orthokeratology, rigid gas permeable lenses, regular/colored contact lenses, eye supplements, etc.; eye plastic and micro cosmetic surgery; and customized aesthetic medicine consulting. In addition, it engages in the provision of optometric, hospital management, and technical consultancy services; and sales and leasing of medical devices. Universal Vision Biotechnology Co., Ltd. was founded in 1992 and is based in Taipei, Taiwan.

公司管治

截至 無 止,大學光 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中:無;董事會:無;股東權利:無;現金賠償:無。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。